Sign inJoin waitlistJoin the waitlist

JL

Jonathan Licht

Director, The University of Florida Health Cancer Center · Temple University Hospital

Credentials: · · · · ·

History

University of Florida College of Medicine
2023–Present

Harvard University
1985–1987
Internal Medicine
1982–1985
Doctor of Medicine
1978–1982

Research

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation
Cancer Cell · 2010 · 2,289 citations
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Nature · 2008 · 2,011 citations
Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling
Immunity · 2013 · 1,120 citations

SW
Samuel Waxman
15 papers
Ross Levine
9 papers
RS
Rita Shaknovich
8 papers
William Harbour
8 papers · 4 as a resident
Omar Abdel-Wahab
6 papers · 2 as a fellow
MT
Martin Tallman
5 papers
Ben Ebert
4 papers
RB
Richard Bennett
4 papers
Thomas George
4 papers
AP
Adam Polinger
3 papers
Alok Swaroop
3 papers · 2 as a resident
DH
Daniel Haber
3 papers

Grants

Exploring microRNA Degradation in T-Cell Acute Lymphoblastic Leukemia
National Cancer Institute · R01
PI · $2.1M · University of Florida
2023–2028
Histone Fold Mutations in Cancer Pathogenesis
National Cancer Institute · R01
Contact PI · $1.7M · van Andel Research Institute
2022–2027
Characterization and Targeting of the Epigenetic State Underlying Uveal Melanoma Liver Metastasis
National Cancer Institute · R01
PI · $3.2M · h. Lee Moffitt Cancer Ctr & Res Inst
2021–2027
Defining and Targeting Epigenetic Plasticity-Driven Drug Resistance and Immune Escape in Melanoma
National Cancer Institute · R01
PI · $2.4M · h. Lee Moffitt Cancer Ctr & Res Inst
2022–2027